Document:

Exhibit 4.1

 

 

 

	
RIGHTS CERTIFICATE #:

	NUMBER OF RIGHTS: 

                                                                                                                                                                                                        

     

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY'S PROSPECTUS

SUPPLEMENT DATED AUGUST 14, 2017 (THE "PROSPECTUS SUPPLEMENT") AND ARE INCORPORATED HEREIN BY REFERENCE.

COPIES OF THE PROSPECTUS SUPPLEMENT ARE AVAILABLE UPON REQUEST FROM VSTOCK TRANSFER, LLC AND KATALYST SECURITIES LLC, THE INFORMATION AGENTS.

EKSO BIONICS HOLDINGS, INC. 

          Incorporated under the laws of the State of Nevada

NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE 

Evidencing Non-Transferable Subscription Rights to Purchase Common Shares, $0.001 par value, of Ekso Bionics Holdings, Inc.

Subscription Price:   $1.00 per Share

THE SUBSCRIPTION RIGHTS WILL EXPIRE IF NOT EXERCISED ON OR BEFORE 5:00 P.M., EASTERN DAYLIGHT TIME,

ON AUGUST 31, 2017, UNLESS EXTENDED BY THE COMPANY

                      REGISTERED 

                               OWNER:

  

	
 

	
THIS CERTIFIES THAT the registered owner whose name is inscribed hereon is the owner of the number of non-transferable subscription rights ("Subscription Rights") set forth above. Each whole Subscription Right entitles the holder thereof to subscribe for and purchase 1.1608 common shares, with a par value of  $0.001 per share, of Ekso Bionics Holdings, Inc., a Nevada corporation (the "Company"), at a subscription price of $1.00 per share (the "Basic Subscription Right"),  pursuant to a rights offering (the "Rights Offering"), on the terms and subject to the conditions set forth in the Prospectus Supplement and the "Instructions as to Use of Ekso Bionics Holdings, Inc. Rights Certificates" accompanying this Rights Certificate.  If any common shares available for purchase in the Rights Offering are not purchased by other holders of Subscription Rights pursuant to the 

	
 

	
exercise of their Basic Subscription Right or by the Committed Investor (as defined in the Prospectus Supplement) pursuant to the Purchase Commitment (as defined in the Prospectus Supplement) (the "Unsubscribed Shares"), any holder that exercises its Basic Subscription Right in full may subscribe for a number of Unsubscribed Shares pursuant to the terms and conditions of the Rights Offering, subject to proration, as described in the Prospectus Supplement (the "Oversubscription Right"). The Subscription Rights represented by this Rights Certificate may be exercised by completing Forms 1 and 2 on the reverse side hereof and by retuning the full payment of the subscription price for each common share in accordance with the "Instructions as to Use of Ekso Bionics Holdings, Inc. Rights Certificates" that accompany this Rights Certificate.

 

	
 

 

This Subscription Rights Certificate is not valid unless countersigned by the subscription agent and registered by the registrar.

Witness the seal of Ekso Bionics Holdings, Inc. and the signatures of its duly authorized officers.

  

Dated:  August 14, 2017

COUNTERSIGNED AND REGISTERED:

By: _____________________________

      VSTOCK TRANSFER, LLC

 

 

	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	
Chief Executive Officer & President

	 	
Chief Financial Officer, Secretary & Treasurer

	 

                                                

                                                                                                                               

DELIVERY OPTIONS FOR SUBSCRIPTION RIGHTS CERTIFICATE

          Delivery may be made by mail, hand, express mail, courier or other expedited service to the following address:

VStock Transfer, LLC

18 Lafayette Place

Woodmere, New York 11598

Delivery other than in the manner or to the address set forth above will not constitute valid delivery.

          PLEASE PRINT ALL INFORMATION CLEARLY AND LEGIBLY.

FORM 1—EXERCISE OF SUBSCRIPTION RIGHTS

To subscribe for shares pursuant to your Basic Subscription Right, please complete lines (a) and (c) and sign under Form 2 below. To subscribe for shares pursuant to your Oversubscription Right, please also complete line (b) and sign under Form 2 below. To the extent you subscribe for more common shares than you are entitled under either the Basic Subscription Right or the Oversubscription Right, you will be deemed to have elected to purchase the maximum number of shares for which you are entitled to subscribe under the Basic Subscription Right or Oversubscription Right, as applicable.

(a) EXERCISE OF BASIC SUBSCRIPTION RIGHT:

I apply for ______________ shares x $ 1.00                     =   $_______________

   (no. of new shares)            (subscription price)        (amount enclosed)

(b) EXERCISE OF OVERSUBSCRIPTION RIGHT

If you have exercised your Basic Subscription Right in full and wish

 to subscribe for additional shares pursuant to your Oversubscription Right:

I apply for ______________ shares x $ 1.00                    =   $_______________

  (no. of new shares)              (subscription price)      (amount enclosed)

(c) Total Amount of Payment Enclosed   =   $__________________

METHOD OF PAYMENT (CHECK ONE)

		☐	
Certified or uncertified check drawn against a U.S. bank payable to "VStock Transfer, LLC (acting as Subscription Agent for Ekso Bionics Holdings, Inc.)"

		☐	
Bank check (cashier's check) drawn against a U.S. bank payable to "VStock Transfer, LLC (acting as Subscription Agent for Ekso Bionics Holdings, Inc.)"

		☐	
Wire transfer of immediately available funds directly to the account maintained by VStock Transfer, LLC, as Subscription Agent, for purposes of accepting subscriptions in this Rights Offering at CitiBank, N.A., 530 Central Avenue, Cedarhurst, NY 11516, Account name: Ekso Bionics Holdings, Inc., Routing #021000089, Account #6782422781, Swift # CitiUS33, with reference to the Subscription Rights holder's name.

 

FORM 2—SIGNATURE

TO SUBSCRIBE: I acknowledge that I have received the Prospectus Supplement for this Rights Offering and I hereby irrevocably subscribe for the number of shares indicated above on the terms and conditions specified in the Prospectus Supplement.  I agree to cooperate with the Company and provide to the Company any and all information requested by the Company in connection with the exercise of the rights granted in the previous sentence.

Signature(s): ______________________________________________________

IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this Subscription Rights Certificate in every particular, without alteration or enlargement, or any other change whatsoever.          

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FOR INSTRUCTIONS ON THE USE OF EKSO BIONICS HOLDINGS, INC. SUBSCRIPTION RIGHTS CERTIFICATES, CONSULT VSTOCK TRANSFER, LLC OR KATALYST SECURITIES LLC, THE INFORMATION AGENTS, AT 212-828-8436 OR 212-400-6993, RESPECTIVELY.Lithium Exploration Group, Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

DEBT SETTLEMENT AGREEMENT 

THIS DEBT SETTLEMENT AGREEMENT is made as of the 11th
day of August, 2017 

AMONG: 

Concord Holding Group, LLC with
an address at
 ____________________________________ 

(the "Company") 

AND: 

LITHIUM EXPLORATION GROUP,
INC., a Nevada corporation 
with offices at 4635 S. Lakeshore Dr. Ste
200, Tempe, AZ 85282 
(the "Debtor") 

WHEREAS: 

	A. 	
      As at the date hereof, the Debtor is indebted to the
      Company in the amount of US$1,670,450.91 (the "Loans"), in
      principal , pursuant to the terms of various convertible notes
      (collectively, the "Notes") as outlined in Schedule "A";
  and

	 	 
	B. 	
      The Company and the Debtor have agreed to forbear
      enforcement of the Loans and enter into an amended Note Agreement (the
      "Amended Note Agreement"), in form attached hereto as Schedule "B"
      to provide for certain amendments to the terms and conditions of the Notes
      and pursuant to the exchange of certain covenants specified
  herein.

NOW THEREFORE THIS DEBT SETTLEMENT AGREEMENT WITNESSETH
that in consideration of the mutual covenants and agreements among the
parties and the exchange of covenants, representations and warranties pursuant
to the Amended Note Agreement that has been signed by each of the parties to
each of the other parties, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows: 

	1. 	
      The Debtor hereby agrees to:

	 	(a) 	
      deliver herewith the Amended Note Agreement, to be dated
      and effective as at August 11, 2017 as attached as Schedule "A" to this
      Debt Settlement Agreement;

	 	 	 
	 	(b) 	
      issue concurrently herewith to the Company $400,000
      common stock share purchase warrants (the "Warrants"), with
      $200,000 of the Warrants exercisable at $0.0025 per additional Common
      Share, and the remaining $200,000 of the warrants exercisable at $0.0035
      per additional Common share (subject to certain closing price
      adjustments), or pursuant to “cashless exercise” provisions, for a period
      of five years.

	2. 	
      The Company hereby agrees to forebear on enforcing the
      current Notes;

	 	 
	3. 	
      The parties hereto confirm that the Amended Note
      Agreement shall come into effect upon
execution;

	4. 	
      This Debt Settlement Agreement shall enure to the benefit
      of and be binding upon the parties and their respective successors and
      permitted assigns.

	 	 
	5. 	
      Time is of the essence.

	 	 
	6. 	
      This Debt Settlement Agreement may be executed and
      delivered in any number of counterparts, by facsimile copy, by electronic
      or digital signature or by other written acknowledgment of consent and
      agreement to be legally bound by its terms. Each counterpart when executed
      and delivered will be considered an original but all counterparts taken
      together shall constitute one and the same
instrument.

IN WITNESS WHEREOF the parties hereto have hereunto
executed this Debt Settlement Agreement by its officers duly authorized on their
behalf effective as of the day and year first above written. 

Concord Holding Group, LLC

	 	 
	Name:Name: 	 
	Title:Title: 	 

LITHIUM EXPLORATION GROUP, INC.

	 	 
	Name: 	 
	Title: 	 

SCHEDULE "A" 

	Funding Date 	Note Amount 	Balance (Principal
      amount) 
	9/9/2016 	$64,400.05 	$20,925.05

	9/8/2016 	$27,777.78 	$27,777.78 
	9/15/2016 	$257,778.00 	$4,719.48 
	9/29/2016 	$61,112.00 	$61,112.00 
	10/31/2016 	$163,334.00 	$163,334.00
  
	11/14/2016 	$31,111.00 	$31,111.00 
	11/30/2016 	$100,000.00 	$100,000.00
  
	12/29/2016 	$91,111.00 	$14,363.29 
	1/25/2017 	$132,222.00 	$115,139.31
  
	1/26/2017 	$99,833.00 	$99,833.00 
	3/1/2017 	$183,056.00 	$183,056.00
  
	3/13/2017 	$85,800.00 	$85,800.00 
	3/28/2017 	$141,680.00 	$141,680.00
  
	5/5/2017 	$28,600.00 	$28,600.00 
	5/15/2017 	$343,200.00 	$343,200.00
  
	5/15/2017 	$343,200.00 	$164,000.00 
	6/8/2017 	$85,800.00 	$85,800.00

	6/8/2017 	$85,800.00 	$0

SCHEDULE "B" 

FURTHER AMENDED CONVERTIBLE LOAN AGREEMENT is made as of
the 11th day of August, 2017. 

BETWEEN: 

Lithium Exploration Group,
Inc., a company incorporated under 
the laws of the State of Nevada,
having an office at
4635 S. Lakeshore Dr. Ste 200, Tempe, AZ 85282

(hereinafter called, the "Borrower") 

AND: 

Concord Holding Group, LLC with
and address at _____________

(hereinafter called, the "Lender")

WHEREAS:

	A. 	
      The Lender has, pursuant to various convertible notes
      (collectively, the "Note Agreements"), advanced funds to the
      Borrower, in the principal amount of $1,670,450.91 as at the date hereof;
      and

	 	 
	B. 	
      The Borrower and the Lender now wish to make certain
      further amendments to the provisions of the Note
  Agreements.

NOW THEREFORE THIS THIRD AMENDMENT TO CONVERTIBLE LOAN
AGREEMENT WITNESSETH that in consideration of these premises and for other
good and valuable consideration, the receipt and sufficiency of which is also
hereby acknowledged by each of the parties hereto, the parties hereto hereby
agree as follows: 

	1. 	
      All capitalized terms not otherwise defined herein shall
      have the meanings set out in the Note Agreements.

	 	 	 
	2. 	
      As an extension/forbearance fee the Borrower shall issue
      to the Lender $400,000.00 Common Share purchase warrants with the
      following terms:

	 	 	 
		(a) 	
      1⁄2 of the warrants exercisable at $0.0025 per additional
      Common Share;

	 	 	 
		(b) 	
      the remaining 1⁄2 of the warrants exercisable at $0.0035
      per additional Common Share;

	 	 	 
		(c) 	
      the warrants shall provide for “cashless exercise”
      provisions;

	 	 	 
		(d) 	
      the terms of the warrants shall be for a period of 5
      years from the date hereof; and

	 	 	 
		(e) 	
      if the Borrower’s shares of common stock closes at or
      below .0005 for a period of 3 days the above warrant exercise prices
      adjust to 300% and 400% of the lowest trading
price).

	3. 	
      The conversion price related to the discount amount under
      the Note Agreements is amended from a 50% discount to a 25%
    discount..

	 	 
	4. 	
      In all other respects the terms and conditions of the
      Note Agreements shall continue in full force and effect and the Lender
      hereby agrees and confirms that the Note Agreements is in good standing
      and that the Borrower is not in default of any of its obligations under
      the Note Agreements.

	 	 
	5. 	
      Each of the parties hereto agrees to do and/or execute
      all such further and other acts, deeds, things, devices, documents and
      assurances as may be required in order to carry out the true intent and
      meaning of this Amending Agreement.

	 	 
	6. 	
      This Amending Agreement shall enure to the benefit of and
      be binding upon the parties hereto and each of their successors and
      permitted assigns, as the case may be.

	 	 
	7. 	
      This Amending Agreement may be executed in counterparts
      and by electronic or facsimile transmission, each of which shall be deemed
      to be an original and all of which shall constitute one and the same
      document.

[Signature Page Follows] 

IN WITNESS WHEREOF, the parties hereto have executed
this Amending Agreement as of the day and year first above written. 

Concord Holding Group, LLC 

	By: 	  	 
	Its: 	PresidentPresident andand CECEO
    	 

LITHIUM EXPLORATION GROUP, INC. 

	By: 	  	 
	Its: 	President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]